Dual Biologic Therapy for Refractory Crohn's Disease With Perforation in a Patient Declining Surgical Intervention

Dual biologic therapy can improve clinical, biomarker, and endoscopic outcomes in selected patients with refractory Crohn's disease in whom multiple biologics had failed. We presented a patient with refractory Crohn's disease who was admitted for terminal ileal perforation, massive bloody...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Puo-Hsien, Chen, Chien-Ming, Kuo, Chia-Jung, Su, Ming-Yao, Chiu, Cheng-Tang, Tsou, Yung-Kuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629729/
https://www.ncbi.nlm.nih.gov/pubmed/37941582
http://dx.doi.org/10.14309/crj.0000000000001203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629729/
https://www.ncbi.nlm.nih.gov/pubmed/37941582
http://dx.doi.org/10.14309/crj.0000000000001203

Ejemplares similares